News
AngioDynamics, Inc. has announced FDA 510(k) clearance for Oncobionic, Inc. to market Irreversible Electroporation (IRE) ...
December 03, 2006
News
Possis Medical, Inc. has received clearance from the FDA to market its AngioJet Xpeedior catheter to remove blood clots (thrombus) from upper- and lower-extremity peripheral veins. Used with the company’s AngioJet System, Xpeedior is the only device cleared for thrombectomy in peripheral veins.
December 03, 2006News
The Third International Conference on Cell Therapy for Cardiovascular Diseases will convene Jan 17 to 19, at The New York Academy of Medicine in New York, NY. The three-day program is dedicated to the evolving field of cell-based therapies for cardiac repair and regeneration.
November 29, 2006Sponsored Content
Feature | Nuclear Imaging
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 12, 2025News
GE Healthcare has launched its new LightSpeed VCT XT, the industry’s first CT scanner that maintains outstanding image ...
November 29, 2006News
An implantable technology to control high blood pressure in patients not responding to available medicines has ...
November 29, 2006News
The FDA has cleared Toshiba's new EXCELART Vantage Atlas 1.5T MRI system, which the company showcased this week during ...
November 29, 2006Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025News
An innovative lead insulation material for cardiac leads used with pacemakers and ICDs is now FDA approved and available ...
November 29, 2006News
November 2006 - Toshiba America Medical Systems, Inc. has announced a new partnership with CVCTA Education and San ...
November 20, 2006News
In its third quarter financial report, San Diego-based Cytori said it has moved significantly closer to initiating its cardiovascular clinical trials," said Christopher J. Calhoun, chief executive officer of Cytori Therapeutics. The company is developing adipose stem cells in cardiovascular disease and for use in reconstructive surgery.
November 20, 2006Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
Houston based ThromboVision, Inc. has won the first annual Michael E. DeBakey Life Science Award, which carries a $50,000 cash prize to assist in propelling the company's technology toward commercial success.
November 20, 2006News
The stent market will have a distinctly different look after Johnson & Johnson completes its acquisition of Conor ...
November 19, 2006News
A German physician reports that people who have implanted pacemakers or defibrillators are not in danger of their ...
November 19, 2006Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Technology
Siemens Medical Solutions’ ACUSON Antares ultrasound system, premium edition, features shared service cardiology ...
November 16, 2006
Case Study
Training physicians, especially cardiac specialists, has taken on an increasingly critical role. With more cardiologists, cardiovascular surgeons and vascular surgeons interpreting CT data, the need for proper training has increased exponentially in recent years.
November 16, 2006
Feature
The tiny tools of interventional cardiology known as drug-eluting stents (which happen to comprise a gargantuan U.S ...
November 16, 2006